insights_auto
Why is PLUR down 15.00%?
Dive Deeperchevron_right
PLUR:NASDAQ
Pluri Inc
$0.85
arrow_downward
-15.00%(-0.15) 1D
Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLUR...
Open
$0.97
High
$0.97
Low
$0.85
Mkt. cap
10.49M
Avg. vol.
22.21K
Volume
1.45K
52-wk high
$4.86
52-wk low
$0.85
EPS
-$2.44
Beta
0.69
Shares outstanding
12.61M
No. of employees
103
Open
$0.97
High
$0.97
Low
$0.85
Mkt. cap
10.49M
Avg. vol.
22.21K
Volume
1.45K
52-wk high
$4.86
52-wk low
$0.85
EPS
-$2.44
Beta
0.69
Shares outstanding
12.61M
No. of employees
103
News stories
From web sources and news partners
www.dars.gov.et
·
1 week ago
PLUR Q2 2026 Earnings: Wider-Than-Expected Loss Weighs on Shares - Analyst Earnings Estimate
Profile
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas. Wikipedia
About Pluri Inc
CEOYaky Yanay
Employees103
FoundedMay 11, 2001
HeadquartersHaifa, Haifa District, Israel
SectorBiotechnology
Websitepluri-biotech.com